Back to overview

Meet Neumirna at Conferences and Events in 2026

Find out where you can connect with our team this year

Throughout the year, we will be present at leading scientific conferences in our therapeutic areas, as well as key investor and partnering events across the biotech industry.

These events will be our primary touchpoints for sharing updates on our pipeline, scientific progress, and microRNA targeting approach.

We look forward to connecting with partners, investors, and the broader scientific community.

Investor & Partnering Conferences

BioEquity Europe 2026 – Prague, Czech Republic
May 4–6, 2026

BIO International Convention – San Diego, USA
June 22–25, 2026

Nordic Life Science Days (NLS Days) – Stockholm, Sweden
September 8–9, 2026

BIO Europe 2026 – Cologne, Germany
November 9–11, 2026

Jefferies Global Healthcare Conference – London, UK
November 16–19, 2026

Scientific & Clinical

MJFF Q1 Therapeutic Stewardship Meeting – New York, USA
March 11, 2026

AD/PD 2026 – Copenhagen, Denmark
March 17–21, 2026

2026 Research Roundtable for Epilepsy – Washington DC, USA
April 30–May 1, 2026

German Society for Epileptology (DGfE) Annual Meeting – Würzburg, Germany
June 10–13, 2026

Epilepsy Pipeline Conference 2026 – Leesburg, VA, USA
June 18–19, 2026

American Epilepsy Society 2026 – Denver, Colorado, USA
December 4-8, 2026

Funding
Publication
27.3.2026
Meet Neumirna at Conferences and Events in 2026
Find out where you can connect with our team this year
Read full article
Development
Publication
12.1.2026
Neumirna at AES: new data on NMT.001
At the American Epilepsy Society Annual Meeting, Neumirna presented two posters highlighting the potential of its RNA-based approach for drug-resistant epilepsy.
Read full article
Funding
Awards
12.6.2025
Neumirna Receives 2024 CURE Epilepsy Catalyst Award
$250,000 in funding to support biomarker research and development of RNA therapy for drug-resistant epilepsy
Read full article